Post by UZH Faculty of Medicine

Could popular metabolic treatments hold the key to slowing down how quickly our brains age? An interdisciplinary team of researchers has launched the PROMOTE project to investigate whether GLP-1 receptor agonists, commonly known as the active ingredients in diabetes and weight loss therapies, can protect the brain. Supported by a generous four million Swiss Franc grant from the Horten Health Foundation, the study will examine if these well-tolerated metabolic drugs can actively slow down age-related changes in the brain and preserve cognitive fitness. 💡 Why it matters: Maintaining brain health is crucial for preserving mental independence, memory, and psychological well-being as we age. A prematurely aged brain is strongly linked to cognitive decline and mental health disorders, meaning successful preventive treatments could transform healthy aging and significantly reduce the societal burden of age-related illnesses. 👥 Shoutout to Philipp Homan, Flurin Cathomas, Heike A. Bischoff-Ferrari, and Tony Wyss-Coray, alongside the incredible teams at University of Zurich, the Psychiatrische Universitätsklinik Zürich, University of Basel, Stanford University, and the Horten Health Foundation for driving this vital, collaborative research forward! 📖 Read the full story here: https://lnkd.in/eWyJqAyH #BrainHealth #HealthyAging #Neuroscience #ClinicalResearch #MedicalInnovation